Clinical Trial Update: A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study evaluating the efficacy and safety of IBI112 in adolescent participants with moderate to severe plaque psor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• IBI112

Snippet

Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. | Conditions: Psoriasis | Phase 3 | Status: RECRUITING